Innovent Biologics Investor Relations Material

Innovent Biologics Inc. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of biologic drugs, primarily targeting oncology, autoimmune, metabolic, and ophthalmology diseases. The company develops monoclonal antibodies and other biologic therapies aimed at addressing unmet medical needs, particularly within the Chinese market. The company is headquartered in Suzhou, China, and its shares are listed on the Hong Kong Stock Exchange.